Karsy et al. found the subtypes were linked with some biomarkers, such as PDGFRA with proneural, NF1 with mesenchymal, ATRX mutation with astrocytomas, and pTERT mutation with oligdendrocytomas [31]. Here, NF1 is linked to astrocytoma (excluding glioblastoma).